Revised SPC: Bonjela (lidocaine/cetylpyridinium) Junior Gel

Infant teething pain indication has been removed and use restricted to age over 5 months, and addition of warning that excessive dosage, short intervals between doses or use on traumatised mucosa may result in high plasma levels and serious adverse effects.


electronic Medicines compendium